Skip to content

Model 439-07 and 439-09 Lifeline Myocardial Lead

by Intermedics, Inc.

510(k) K880551

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK880551 Date7 Mar 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 439-07 and 439-09 Lifeline Myocardial Lead is a Permanent Pacemaker Electrode, designed for implantation within the heart to deliver electrical stimulation. These leads facilitate cardiac pacing by transmitting electrical impulses to the myocardium, ensuring proper heart rhythm regulation for patients with bradycardia or conduction disorders.

These leads are intended for single-use implantation in cardiac pacing procedures, supplied sterile and intended for use in clinical settings. They are classified as Class III devices under FDA regulations and have been granted FDA 510(k) clearance as substantially equivalent to predicate devices. Proper handling, storage, and adherence to manufacturer instructions are required to maintain sterility and functionality.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these leads designed for reuse in multiple patients or intended as single-use implants?

    These leads are explicitly designed for single-use implantation in cardiac pacing procedures. They are supplied sterile and intended for use in one patient only, per manufacturer instructions. Reuse is not recommended to maintain sterility and functionality.

  • What storage conditions should be followed to preserve sterility and functionality of the Model 439-07 and 439-09 leads?

    The leads must be stored according to the manufacturer’s guidelines to ensure sterility and performance. While specific conditions aren’t detailed here, typical best practices for sterile, single-use medical devices—such as keeping them in sealed, unopened packaging, away from extreme temperatures, and protecting from moisture or contamination—should be followed. Always refer to Intermedics’ instructions for precise storage requirements.

  • What distinguishes the Model 439-07 from the Model 439-09 in terms of clinical application?

    The distinction between the Model 439-07 and Model 439-09 is not explicitly detailed in the provided data, but both are classified as *Permanent Pacemaker Electrodes* for delivering electrical stimulation to the myocardium. Differences in design (e.g., lead length, electrode configuration, or pacing thresholds) would typically be specified in the manufacturer’s documentation. For precise clinical application guidance, consult Intermedics’ technical literature or product specifications.

  • How were these leads evaluated for regulatory clearance, and what committee reviewed their submission?

    The Model 439-07 and 439-09 leads underwent a Traditional 510(k) review process with the FDA, classified under the Cardiovascular (CV) advisory committee. The submission was deemed *substantially equivalent* to predicate devices, as indicated by the decision code SESE. The review panel assessed their safety and effectiveness for use as permanent pacemaker electrodes, ensuring compliance with FDA regulations for Class III devices.